RNU6-405P

Across TCGA pan-cancer cohorts, RNU6-405P RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated RNU6-405P data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher RNU6-405P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-405P expression acts as an unfavorable survival marker.

BLCA, HNSC, and KIRP are the cancer types where RNU6-405P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	OS	Tertile	All	0.135	0.711	<.001	198	view →
HNSC	OS	Tertile	All	0.141	0.663	<.001	180	view →
KIRP	OS	Tertile	All	0.180	0.904	<.001	45	view →
BRCA	DFS	Tertile	All	0.781	0.951	<.001	42	view →
STAD	OS	Tertile	IV	0.074	0.496	.002	36	view →
SKCM	DFS	Tertile	III,IV	0.040	0.613	<.001	36	view →
SARC	DFS	Tertile	All	0.069	0.632	<.001	27	view →
LUAD	OS	Tertile	All	0.398	0.838	<.001	18	view →
PRAD	OS	Tertile	All	0.811	0.990	<.001	18	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

RNU6-405P–BLCA (OS)

Open the BLCA breakdown →